.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The recent Torrent Diagnostics launch marks a significant shift in India's healthcare landscape. Torrent Group, a prominent pharmaceutical name, has officially entered the diagnostics sector. They established a massive 100,000-square-foot National Reference Laboratory (NRL) in Navi Mumbai. This facility aims to redefine testing standards through advanced technology and scientific depth.
This expansion supports 15 diagnostic disciplines and more than 3,500 test modalities. Consequently, the lab covers everything from routine blood work to highly specialized genetic sequencing. The facility utilizes cutting-edge tools such as Next-Generation Sequencing (NGS) and MALDI-TOF. Additionally, it houses the first Transmission Electron Microscope in a standalone lab in Western India. Therefore, clinicians can expect high-precision results for complex cases.
Furthermore, the lab includes BSL-3 containment for infectious disease workflows. This ensures safe handling of high-risk pathogens while maintaining rigorous quality standards. The scientific team brings extensive domain leadership to ensure compliance and accuracy across all departments.
According to Varun Mehta, Director at Torrent Group, the company approaches this venture with a long-term perspective. They believe trust in diagnostics stems from process integrity and scientific consistency. By anchoring the organization around a central reference laboratory, they can offer one of the widest test menus. Moreover, this structure allows for robust governance and validation frameworks.
Consequently, the launch provides a strong scientific foundation for the group's diagnostic services. The facility aims to serve as a hub for innovation and excellence in pathology and genomics. As a result, healthcare providers in the region gain access to world-class diagnostic capabilities.
Q1: What specialized technologies are available at the new Navi Mumbai laboratory?
The laboratory features advanced capabilities including Next Generation Sequencing (NGS), MALDI-TOF, BSL-3 containment, and a Transmission Electron Microscope.
Q2: How many test modalities does the Torrent National Reference Laboratory offer?
The facility supports over 3,500 test modalities across 15 diagnostic disciplines, including molecular diagnostics and genomics.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Torrent Group launches Torrent Diagnostics and India’s largest National Reference Laboratory in Navi Mumbai, offering 3,500+ tests including genomics....
6 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
Explore real-world data showing how private oncogenetics and molecular tumor boards achieve 3-week consult turnaround, high ctDNA actionability, and vital germline variant detection, enhancing individualized cancer care and familial risk assessment.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
